pharmacie et médicaments – Traitement contre le cancer du myélome.

This written question asks about the availability of cancer treatments for myeloma patients in France. It highlights concerns regarding access to specific drugs and potential delays in treatment. The question seeks clarification from the government on measures being taken to ensure timely access to essential cancer medications for all patients.